SII & Gates MRI ink pact to manufacture new TB vaccine candidate after successful Phase 3 trials | Pune News
An AI-generated illustration shows workers in protective gear overseeing large-scale tuberculosis (TB) vaccine manufacturing at a modern pharmaceutical plant in India Pune: Serum Institute of India (SII) and Gates Medical Research Institute (Gates MRI) have entered an agreement to manufacture M72/AS01E, a novel tuberculosis (TB) vaccine candidate.The clinical trial of the vaccine candidate is in…
